Keywords: GenVec, Malaria vaccine

GenVec presents encouraging data from malaria vaccine study

Article | 13 April 2010

In an announcement that has been widely anticipated, Maryland, USA-based biotechnology firm GenVec presented encouraging clinical and preclinical malaria vaccine ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GenVec

Go to company listing